Alpha-1 Antitrypsin Deficiency (AATD) Augmentation Therapy Market Size, Share and Industry Analysis by Product Type (Glassia, Aralast NP, Prolastin C, Zemaira/Respreeza), End User (Hospitals, Specialty Clinics) and Regional Forecast, 2019 - 2026
| Report Id | License Type | Price |
|---|---|---|
| FBI100169 | $ 4850 | |
| Total | $ 4850 | |